DAIRY KLEEN GENERAL PURPOSE ALKALINE DETERGENT Australia - engleză - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dairy kleen general purpose alkaline detergent

ecolab pty ltd - alkaline salts - wettable powder - alkaline salts cleanser/sanitiser active 775.0 g/kg - dairy cleanser - milking equipment | milking machine - residue, dirt in milking equipment

Gastrografin Oral Liquid Bottle Australia - engleză - Department of Health (Therapeutic Goods Administration)

gastrografin oral liquid bottle

bayer australia ltd - amidotrizoate meglumine, quantity: 660 mg/ml; sodium amidotrizoate, quantity: 100 mg/ml - oral liquid, solution - excipient ingredients: disodium edetate; anise oil; polysorbate 80; saccharin; purified water - gastrografin is a contrast medium for examination of the gastrointestinal tract. it can be administered orally and as enema and is primarily indicated in cases in which the use barium sulfate is unsatisfactory, undesirable or contraindicated. among these are: - suspected partial or complete stenosis - acute haemorrhage - threatening perforation (peptic ulcer, diverticulum) - other acute conditions which are likely to require surgery - after resection of the stomach or the intestine (danger of perforation or leak) - megacolon - visualisation of a foreign body or tumour before endoscopy - visualisation of gastrointestinal fistula. in addition to these conditions gastrografin can generally be used for the same purposes as barium sulfate with the exception of the visualisation of mucosal diseases. due to the insufficient coating properties of gastrografin, barium sulfate should be used for single or double contrast techniques. in combination with barium sulfate, gastrografin has considerably improved routine inve

TEVA-THEOPHYLLINE SR TABLET (EXTENDED-RELEASE) Canada - engleză - Health Canada

teva-theophylline sr tablet (extended-release)

teva canada limited - theophylline - tablet (extended-release) - 100mg - theophylline 100mg - respiratory smooth muscle relaxants

TEVA-THEOPHYLLINE SR TABLET (EXTENDED-RELEASE) Canada - engleză - Health Canada

teva-theophylline sr tablet (extended-release)

teva canada limited - theophylline - tablet (extended-release) - 200mg - theophylline 200mg - respiratory smooth muscle relaxants

TEVA-THEOPHYLLINE SR TABLET (EXTENDED-RELEASE) Canada - engleză - Health Canada

teva-theophylline sr tablet (extended-release)

teva canada limited - theophylline - tablet (extended-release) - 300mg - theophylline 300mg - respiratory smooth muscle relaxants

CAPOTEN captopril 5mg/mL oral liquid bottle Australia - engleză - Department of Health (Therapeutic Goods Administration)

capoten captopril 5mg/ml oral liquid bottle

arrotex pharmaceuticals pty ltd - captopril, quantity: 5 mg/ml - oral liquid, solution - excipient ingredients: sodium benzoate; hydrochloric acid; sodium hydroxide; sodium citrate dihydrate; disodium edetate; purified water; citric acid - 1.hypertension: capoten (captopril) is indicated for the treatment of hypertension. in using capoten, consideration should be given to the risk of neutropenia/agranulocytosis (see precautions). capoten is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. the blood pressure lowering effects of captopril and thiazides are approximately additive. 2. myocardial infarction: capoten is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction less than or equal to 40%, and to reduce the incidence of overt heart failure and subsequent hospitalisations for congestive heart failure in these patients. the efficacy data for the use of captopril following myocardial infarction are strongest for initiation of therapy beyond 3 days post-infarct. 3. heart failure: capoten (captopril) is indicated for the treatment of heart failure. in symptomatic patients it is recommended that capoten be administered together with a diuretic. 4. diabetic nephropathy: capoten is indicated for the treatment of diabetic nephropathy in patients with type 1 insulin- dependent diabetes mellitus.

RIBOMUSTIN bendamustine hydrochloride 25 mg powder for injection vial Australia - engleză - Department of Health (Therapeutic Goods Administration)

ribomustin bendamustine hydrochloride 25 mg powder for injection vial

janssen-cilag pty ltd - bendamustine hydrochloride, quantity: 25 mg - injection, powder for - excipient ingredients: mannitol - first-line treatment of chronic lymphocytic leukaemia (binet stage b or c). efficacy relative to first-line therapies other than chlorambucil has not been established. previously untreated indolent cd20-positive, stage iii-iv non-hodgkin?s lymphoma, in combination with rituximab. previously untreated cd20-positive, stage iii-iv mantle cell lymphoma in combination with rituximab, in patients ineligible for autologous stem cell transplantation. relapsed/refractory indolent non-hodgkin?s lymphoma.

RIBOMUSTIN bendamustine hydrochloride 100 mg powder for injection vial Australia - engleză - Department of Health (Therapeutic Goods Administration)

ribomustin bendamustine hydrochloride 100 mg powder for injection vial

janssen-cilag pty ltd - bendamustine hydrochloride, quantity: 100 mg - injection, powder for - excipient ingredients: mannitol - first-line treatment of chronic lymphocytic leukaemia (binet stage b or c). efficacy relative to first-line therapies other than chlorambucil has not been established. previously untreated indolent cd20-positive, stage iii-iv non-hodgkin?s lymphoma, in combination with rituximab. previously untreated cd20-positive, stage iii-iv mantle cell lymphoma in combination with rituximab, in patients ineligible for autologous stem cell transplantation. relapsed/refractory indolent non-hodgkin?s lymphoma.